End stage renal disease.
Hall
Yoshio N
YN
Division of Nephrology, Department of Medicine, University of California San Francisco, San Francisco General Hospital, San Francisco, California, USA.
Chertow
Glenn M
GM
D015314:Dialysis Solutions / Q000627:therapeutic use; D005936:Glucans / Q000627:therapeutic use; D005947:Glucose / Q000627:therapeutic use; D006801:Humans; D000077607:Icodextrin; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy*; D010530:Peritoneal Dialysis / Q000009:adverse effects; D006435:Renal Dialysis / Q000009:adverse effects
D015314:Dialysis Solutions; D005936:Glucans; D000077607:Icodextrin; D005947:Glucose